Fluvoxamine treatment for chronic PTSD: a pilot study.
A group of 24 Dutch World War II Resistance veterans with a documented traumatic war history and a (partially) positive diagnosis of current posttraumatic stress disorder (PTSD) was studied. This special group of war victims is characterised by chronicity, suffering from intractable posttraumatic complaints for decades. They were treated with fluvoxamine (Fevarin), a selective serotonin reuptake inhibitor with antidepressive and anxiolytic properties. The study was designed as an open-ended, outpatient pilot study, with a treatment period of 12 weeks. Results of clinical examination, and questionnaires investigating PTSD, depression, sleeping problems, anxiety, and vital exhaustion indicate that a significant number of the subjects improved with respect to their PTSD symptomatology, and their symptoms of anxiety and vital exhaustion. However, at the end of the study, quantitative improvement was modest. The results indicate that treatment with fluvoxamine may offer alleviation of chronic PTSD symptoms, in particular insomnia, nightmares, anxiety, intrusive recollections, guilt feelings and tiredness.
De Boer
M
M
Department of Psychiatry, St. Lucas Hospital, Amsterdam, The Netherlands.
Op den Velde
W
W
Falger
P J
PJ
Hovens
J E
JE
De Groen
J H
JH
Van Duijn
H
H
D000368:Aged; D003130:Combat Disorders / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016666:Fluvoxamine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009426:Netherlands; D010865:Pilot Projects; D014728:Veterans / Q000523:psychology*
D016666:Fluvoxamine